|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.26 USD | -3.44% |
|
-10.83% | -4.83% |
| Dec. 05 | Deutsche Bank Adjusts Price Target on HealthEquity to $120 From $117, Maintains Buy Rating | MT |
| Dec. 03 | HealthEquity, Inc., Q3 2026 Earnings Call, Dec 03, 2025 |
| Capitalization | 8.07B 6.95B 6.52B 6.07B 11.18B 728B 12.2B 76.04B 29.44B 344B 30.3B 29.66B 1,259B | P/E ratio 2026 * |
40.6x | P/E ratio 2027 * | 33.6x |
|---|---|---|---|---|---|
| Enterprise value | 8.67B 7.47B 7.01B 6.52B 12.01B 782B 13.1B 81.69B 31.63B 369B 32.56B 31.86B 1,353B | EV / Sales 2026 * |
6.62x | EV / Sales 2027 * | 5.83x |
| Free-Float |
98.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HealthEquity, Inc.
| 1 day | -3.44% | ||
| 1 week | -10.83% | ||
| Current month | -13.18% | ||
| 1 month | -8.52% | ||
| 3 months | -1.87% | ||
| 6 months | -17.85% | ||
| Current year | -4.83% |
| 1 week | 90.92 |  | 104.2 |
| 1 month | 90.92 | | 105.96 |
| Current year | 74.07 | | 116.65 |
| 1 year | 74.07 | | 116.65 |
| 3 years | 48.86 | | 116.65 |
| 5 years | 36.8 | | 116.65 |
| 10 years | 15.8 | | 116.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Cutler
CEO | Chief Executive Officer | 55 | 2025-01-05 |
James Lucania
DFI | Director of Finance/CFO | 46 | 2023-07-30 |
Elimelech Rosner
CTO | Chief Tech/Sci/R&D Officer | 68 | 2022-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Neeleman
BRD | Director/Board Member | 57 | 2002-10-31 |
Evelyn Dilsaver
BRD | Director/Board Member | 70 | 2014-07-31 |
Robert Selander
CHM | Chairman | 74 | 2015-09-29 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 13.28% | 303 M€ | -21.75% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.44% | -10.83% | -9.58% | +41.25% | 8.07B | |
| +1.51% | +0.76% | +9.96% | +98.24% | 3,591B | |
| -0.60% | +7.92% | +149.45% | +2,438.69% | 433B | |
| +0.36% | +9.36% | +9.32% | +106.39% | 91.88B | |
| -0.71% | +5.62% | -8.96% | +40.02% | 88.95B | |
| +4.63% | +6.52% | +156.11% | +2,014.23% | 80.82B | |
| -4.27% | -5.20% | +12.35% | +109.97% | 79.32B | |
| -0.20% | +2.51% | +68.87% | +201.10% | 67.58B | |
| -0.16% | -0.82% | +31.61% | +145.35% | 45.8B | |
| +0.85% | +5.66% | -41.36% | +18.02% | 41.92B | |
| Average | -0.20% | +2.76% | +37.78% | +521.33% | 452.86B | |
| Weighted average by Cap. | +1.14% | -0.15% | +26.16% | +356.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.31B 1.13B 1.06B 985M 1.82B 118B 1.98B 12.35B 4.78B 55.8B 4.92B 4.82B 204B | 1.41B 1.22B 1.14B 1.06B 1.96B 127B 2.14B 13.31B 5.15B 60.16B 5.3B 5.19B 220B |
| Net income | 204M 176M 165M 153M 282M 18.38B 308M 1.92B 743M 8.68B 765M 749M 31.8B | 246M 212M 199M 185M 341M 22.18B 372M 2.32B 897M 10.47B 924M 904M 38.38B |
| Net Debt | 600M 517M 485M 451M 831M 54.11B 907M 5.65B 2.19B 25.55B 2.25B 2.2B 93.61B | 161M 138M 130M 121M 222M 14.48B 243M 1.51B 586M 6.84B 603M 590M 25.05B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-08 | 91.18 $ | -3.52% | 480,219 |
| 25-12-05 | 94.51 $ | -1.21% | 697,997 |
| 25-12-04 | 95.67 $ | -3.01% | 1,554,760 |
| 25-12-03 | 98.64 $ | -0.24% | 1,550,092 |
| 25-12-02 | 98.88 $ | -3.45% | 917,878 |
Delayed Quote Nasdaq, December 08, 2025 at 01:36 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HQY Stock
Select your edition
All financial news and data tailored to specific country editions
